restricted external are we worth it? exploring the economic value of specialist nursing in practice...
TRANSCRIPT
restricted externalrestricted external
Are we worth it?Are we worth it?Exploring the economic value of Exploring the economic value of
specialist nursing in practicespecialist nursing in practice
Jill NichollsJill Nicholls
Heart Failure Specialist NurseHeart Failure Specialist Nursesupported by supported by
Royal College of Nursing and Royal College of Nursing and
Office for Public ManagementOffice for Public Management
restricted externalrestricted external
Project backgroundProject background
Collaborative project between The Royal College of Nursing (RCN) Collaborative project between The Royal College of Nursing (RCN) andand
the Office for Public Management (OPM), funded by the Burdett Trustthe Office for Public Management (OPM), funded by the Burdett Trustfor Nursing to for Nursing to
Equip senior nursing staff with the skills to understand and Equip senior nursing staff with the skills to understand and evidence the economic value of servicesevidence the economic value of services
To ensure that nursing innovations are To ensure that nursing innovations are ‘‘fit for purposefit for purpose’’
To support service review / redesignTo support service review / redesign
First nurses recruited April 2012, training commenced May with First nurses recruited April 2012, training commenced May with submission of economic assessments for verification and submission of economic assessments for verification and publication by Oct 2012publication by Oct 2012
restricted externalrestricted external
Project aimProject aim
To monetise data regarding the acute heart failure admissions To monetise data regarding the acute heart failure admissions with differing managementwith differing management
To explore length of stay associated with differing managementTo explore length of stay associated with differing management
To monetise the cost of SIGN CHF recommended management for To monetise the cost of SIGN CHF recommended management for HFNLS patients in the communityHFNLS patients in the community
To explore patient symptom assessment within the HFNLSTo explore patient symptom assessment within the HFNLS
To identify potential improvements to maximise quality of both To identify potential improvements to maximise quality of both patient care and service delivery across NHS Taysidepatient care and service delivery across NHS Tayside
restricted externalrestricted external
Costs of HF to the UK NHS (2000)Costs of HF to the UK NHS (2000)
Hospital inpatient care
60.5%
Outpatientcare
8%Outpatient investigations
6%
Drugs9%
Primary care
16.5%
Cost elementCost element £ £ millionmillion
Primary carePrimary care 103.8103.8
Hospital inpatient Hospital inpatient carecare 378.6378.6
Day case careDay case care 0.450.45
Outpatient careOutpatient care 51.2551.25
Outpatient Outpatient investigationsinvestigations 37.4437.44
DrugsDrugs 54.0854.08
TotalTotal 625.62625.62
Coronary heart disease statistics: heart failure supplement., BHF 2002, http://www.heartstats.org, accessed 25.02.04.
restricted externalrestricted external
Heart failure therapiesHeart failure therapies
Mortality by 24%(cumulative by 57%)
B-Blockers Mortality by 32 %
(cumulative by 44%)
ACEIs 12 month
mortality by 17 %
Aldosterone antagonists 12 month
mortality by 32%
Mann DL et al. Circulation 2005;111: 2837-2849
restricted externalrestricted external
The Glasgow experienceThe Glasgow experience
Lynda Blue et al 2001Lynda Blue et al 2001 Randomised controlled trial of specialist nurse intervention in Randomised controlled trial of specialist nurse intervention in
heart failureheart failure 165 participants – 75 pts usual care & 82 pts HFNLS (6 withdrew)165 participants – 75 pts usual care & 82 pts HFNLS (6 withdrew) Decompensating heart failure admissions due to Left Ventricular Decompensating heart failure admissions due to Left Ventricular
Systolic Dysfunction (LVSD)Systolic Dysfunction (LVSD) Intervention – home visiting programme, education and ongoing Intervention – home visiting programme, education and ongoing
specialist support by telephonespecialist support by telephone ResultsResults
Reduction in death or readmission due to heart failureReduction in death or readmission due to heart failure Reduction in death or readmission from all causesReduction in death or readmission from all causes If admitted, reduced length of stay If admitted, reduced length of stay
restricted externalrestricted external
•Home visiting model•Individual management plan•Expert symptom & clinical assessment•Optimise medication management•Investigations•Multi-disciplinary team working across all sectors of care•Patient & Carer education •Self monitoring•Rapid response service•Palliative care•Patient discharge if stable > 6mths & optimal medication
•Home visiting model•Individual management plan•Expert symptom & clinical assessment•Optimise medication management•Investigations•Multi-disciplinary team working across all sectors of care•Patient & Carer education •Self monitoring•Rapid response service•Palliative care•Patient discharge if stable > 6mths & optimal medication
Direct•3x WTE Band 7 Heart Failure Specialist Nurses•1x.5 WTE Band 7 Physiotherapist•1x.8 WTE Band 3 Administrative support •NHS Tayside budget•Office space (within NHS Tayside property)•Training •Clinical supplies & equipment•Office supplies & equipment
Direct•3x WTE Band 7 Heart Failure Specialist Nurses•1x.5 WTE Band 7 Physiotherapist•1x.8 WTE Band 3 Administrative support •NHS Tayside budget•Office space (within NHS Tayside property)•Training •Clinical supplies & equipment•Office supplies & equipment
Heart Failure Nurse Liaison Service – ‘Pathway to outcomes’Heart Failure Nurse Liaison Service – ‘Pathway to outcomes’
Staff outcomes•Expert knowledge / confidence in heart failure management•Staff satisfaction due to autonomy of role
Patient outcomes•Improved symptom control results in improved clinical stability•Reduced frequency of hospital admissions•Ongoing support from an expert clinical service•Patient-centred model of care
Organisational outcomes•Reduced costs attached to managing this patient group within a general practice setting•Reduced financial burden associated with an unstable patient group due to reduced bed days and reduced length of stay
Staff outcomes•Expert knowledge / confidence in heart failure management•Staff satisfaction due to autonomy of role
Patient outcomes•Improved symptom control results in improved clinical stability•Reduced frequency of hospital admissions•Ongoing support from an expert clinical service•Patient-centred model of care
Organisational outcomes•Reduced costs attached to managing this patient group within a general practice setting•Reduced financial burden associated with an unstable patient group due to reduced bed days and reduced length of stay
‘A’ grade recommendation from SIGN 95 Management of Chronic Heart Failure 2007 identifies :• Comprehensive discharge planning should ensure links with post-discharge services are in place for all those with symptomatic heart failure. A nurse-led, home based element should be included.
‘A’ grade recommendation from SIGN 95 Management of Chronic Heart Failure 2007 identifies :• Comprehensive discharge planning should ensure links with post-discharge services are in place for all those with symptomatic heart failure. A nurse-led, home based element should be included.
InputInput
Indirect•Travel costs•Non-medical prescribing
Indirect•Travel costs•Non-medical prescribing
Activities & outputsActivities & outputs Groups targetedGroups targeted
For intervention•Patients with Heart Failure due to Left Ventricular Systolic Dysfunction (LVSD), either post admission or remain symptomatic / complex at out-patient clinic assessment
For partnership•Patients•Carers•Acute cardiology services•NHS Tayside Heart Failure Working Group•GP / Practice & District Nursing services •Allied Health Professionals •Social Care services
For delivery•Heart Failure Specialist Nursing Team
For intervention•Patients with Heart Failure due to Left Ventricular Systolic Dysfunction (LVSD), either post admission or remain symptomatic / complex at out-patient clinic assessment
For partnership•Patients•Carers•Acute cardiology services•NHS Tayside Heart Failure Working Group•GP / Practice & District Nursing services •Allied Health Professionals •Social Care services
For delivery•Heart Failure Specialist Nursing Team
OutcomesOutcomes
restricted externalrestricted external
Methods (1)Methods (1)
Clinical audit Clinical audit
Data sourceData source NHS Tayside Information Service Division (ISD)NHS Tayside Information Service Division (ISD)
• Hospital admissions for CHF (Hospital admissions for CHF (primary coding diagnosis of Heart primary coding diagnosis of Heart Failure, Left Ventricular Failure, Non Specific HF and Congestive Failure, Left Ventricular Failure, Non Specific HF and Congestive Cardiac Failure)Cardiac Failure)
To assess the impact of NHS Tayside HFNLSTo assess the impact of NHS Tayside HFNLS Comparison of 2 cohorts of CHF admissions Comparison of 2 cohorts of CHF admissions
• Pre and post service introduction Pre and post service introduction
Jan 2003-04 & Jan 2011-12 Jan 2003-04 & Jan 2011-12
restricted externalrestricted external
Methods (2)Methods (2)
MeasurementsMeasurements
Site of admissionsSite of admissions• To allocate accurate costing for each locationTo allocate accurate costing for each location
Clinical data review via Clinical Portal, SCI & EDDClinical data review via Clinical Portal, SCI & EDD• To verify primary diagnosis codingTo verify primary diagnosis coding
Patient activityPatient activity• Number of Re-admissionsNumber of Re-admissions• Length of stayLength of stay
Quality valueQuality value• NYHA improvement (2011)NYHA improvement (2011)• Patient satisfaction questionnaire (2011 cohort)Patient satisfaction questionnaire (2011 cohort)
restricted externalrestricted external
Methods (3)Methods (3)
Economic costingEconomic costing
Cost per admissionCost per admission• Type of wardType of ward• LocationLocation• Length of stayLength of stay• Inflation adjustment of 2.5% per year to provide actual costingInflation adjustment of 2.5% per year to provide actual costing
Cost per primary care type of contact (mid costs taken)Cost per primary care type of contact (mid costs taken)
Annual running cost of HFNLSAnnual running cost of HFNLS
restricted externalrestricted external
Economic approachesEconomic approaches
A number of economic options are available as guided by H.M.A number of economic options are available as guided by H.M.
Treasury depending on the information available and purpose for Treasury depending on the information available and purpose for studystudy
such as:-such as:-
Cost-benefit analysis - inputs & outputs quantified and monetisedCost-benefit analysis - inputs & outputs quantified and monetised Cost-effectiveness analysis - alternative interventions comparedCost-effectiveness analysis - alternative interventions compared Cost-minimisation analysis - different approaches for same Cost-minimisation analysis - different approaches for same
outcome outcome Cost-consequence analysis - range of benefits from differing Cost-consequence analysis - range of benefits from differing
activitiesactivities Social return on investment - information not normally given cost Social return on investment - information not normally given cost
valuevalue Cost-avoidance analysisCost-avoidance analysis ref OPM Handout 1, 2012ref OPM Handout 1, 2012
restricted externalrestricted external
Initial resultsInitial results
0
10
20
30
40
50
60
70
80
90
100
£370,000
£380,000
£390,000
£400,000
£410,000
£420,000
£430,000
£440,000
£450,000
£460,000
£470,000
£480,000
Total pts re-admitEpisodes of re-admitTotal bed days(10s)Av LOS per admit
RIP re-admits
Cost
Total pts re-admit 41 41
Episodes of re-admit 53 48
Total bed days (10s) 82.7 94.1
Av LOS per admit 15.6 19.6
RIP re-admits 1.00 8.00
Cost £407,848 £471,121
2003-04 2011-12
restricted externalrestricted external
DiscussionDiscussion
Heart Failure admission costs appear increased however this may Heart Failure admission costs appear increased however this may be related to increased number of episodes ending in death be related to increased number of episodes ending in death 2003/04=1 (24 days) v2003/04=1 (24 days) v’’s 2011/12=8 (259 days)s 2011/12=8 (259 days)
Slightly less episodes of re-admission but overall length of stay Slightly less episodes of re-admission but overall length of stay has increased has increased
Average age in 2003/04 was 75yrs, 2011/12 was 79yrs Average age in 2003/04 was 75yrs, 2011/12 was 79yrs
When scrutinised further, data from 2011 / 12 indicates clear When scrutinised further, data from 2011 / 12 indicates clear differences in activity depending on post discharge management – differences in activity depending on post discharge management –
• 132 patients (54%) were referred to the HFNLS132 patients (54%) were referred to the HFNLS• 112 patients (46%) were not referred112 patients (46%) were not referred
restricted externalrestricted external
Activity non ref vActivity non ref v’’s ref patientss ref patients
0
20
40
60
80
100
120
140
£0
£50,000
£100,000
£150,000
£200,000
£250,000
£300,000
Total LVSDadmitsTotal pts re-admit
Episodes of re-admitTotal bed days(10s)Av LOS per admit
Cost
Total LVSD admits 112 132
Total pts re-admit 30 11
Episodes of re-admit 32 16
Total bed days (10s) 66.4 27.7
Av LOS per admit 22.1 17.3
Cost £276,528 £194,593
Not referred Referred
restricted externalrestricted external
Discussion (2)Discussion (2)
Patient location Patient location Referred group NW n87 / PRI n39 / Comm. Hosp n6Referred group NW n87 / PRI n39 / Comm. Hosp n6 Non referred group:- NW n49 / PRI n40 / Comm. Hosp n23Non referred group:- NW n49 / PRI n40 / Comm. Hosp n23
AgeAge Average age of referred group 78yrsAverage age of referred group 78yrs Average age of non referred group 80yrsAverage age of non referred group 80yrs
Co-morbidities Co-morbidities Difficult to establish without full individual review but from HFNLS Difficult to establish without full individual review but from HFNLS
records, patients have between 2-13 documented co-morbiditiesrecords, patients have between 2-13 documented co-morbidities
Palliative Care / End of life – acknowledged this is difficult to predictPalliative Care / End of life – acknowledged this is difficult to predict
but should not preclude patients from specialist inputbut should not preclude patients from specialist input
restricted externalrestricted external
Avoided admission costAvoided admission cost
Comparison between the two groups explores potential efficiencies Comparison between the two groups explores potential efficiencies fromfrom
re-admission ratesre-admission rates
8.3% (n11) of referred pt group re-admitted = 8.3% (n11) of referred pt group re-admitted = £194,593£194,593 26.7% (n30) of non referred pt group re-admitted = 26.7% (n30) of non referred pt group re-admitted = £276,528£276,528
If HFNLS were not in place, it can be assumed that the referred groupIf HFNLS were not in place, it can be assumed that the referred groupwould have resembled non-referred patterns, thereforewould have resembled non-referred patterns, therefore
26.7% of 132 patients (n35) assuming each patient had26.7% of 132 patients (n35) assuming each patient had1.45 admits each @ £9,815 av NHST Cardiac admit = 1.45 admits each @ £9,815 av NHST Cardiac admit = £498,111£498,111
Indicates approx reduced care costs ofIndicates approx reduced care costs of £303,518£303,518
restricted externalrestricted external
CHP associated costsCHP associated costs
Total face to face contacts 2011/12 Total face to face contacts 2011/12 34933493 Total blood tests during same periodTotal blood tests during same period 37313731
515 patients managed within HFNLS during this period515 patients managed within HFNLS during this period Average 7 visits & 7 bloods tests per pt/per yearAverage 7 visits & 7 bloods tests per pt/per year
The CHP cost for equivalent review process:-The CHP cost for equivalent review process:-
£10-12 per Practice Nurse apt (£11 av cost used)£10-12 per Practice Nurse apt (£11 av cost used) £28-35 per GP review (£31 av cost used) £28-35 per GP review (£31 av cost used) ref RCGP Scotland, 2011. A Manifesto for Scotlandref RCGP Scotland, 2011. A Manifesto for Scotland
£294 X 515 patients = avoided costs of£294 X 515 patients = avoided costs of £151,410£151,410
restricted externalrestricted external
Cost commitment for HFNLSCost commitment for HFNLS
HF Specialist Nurse x 3HF Specialist Nurse x 3 1x .8 Administrative Support1x .8 Administrative Support 1x .5 Physiotherapist1x .5 Physiotherapist Supplies - clinicalSupplies - clinical Training BudgetTraining Budget Physical resources eg office furniturePhysical resources eg office furniture Service equipmentService equipment StationeryStationery Travel costsTravel costs
TotalTotal £202,604£202,604
restricted externalrestricted external
Room for improvement?
Total HF admission costs from 2011/12Total HF admission costs from 2011/12 £471,121£471,121
8.3% of HFNLS group re-admit = 8.3% of HFNLS group re-admit = 11 pts with 16 episodes (av adm/pt is 1.45)11 pts with 16 episodes (av adm/pt is 1.45) £194,593£194,593
If non-referred group were under HFNLS model If non-referred group were under HFNLS model assuming 8.3% of 112 pts continue would be 9 pts assuming 8.3% of 112 pts continue would be 9 pts between 1.06between 1.06 & 1.45 adm/pt (9.54 /13 episodes) & 1.45 adm/pt (9.54 /13 episodes) @ NHST HF@ NHST HF average admission cost of £9,815average admission cost of £9,815
Potential range acute cost Potential range acute cost £288,228 - £322,188£288,228 - £322,188
Indicated cost efficiency rangeIndicated cost efficiency range £93,635 -£93,635 - £148,933£148,933
restricted externalrestricted external
Financial SummaryFinancial Summary
Evidenced efficiencies from avoided admissionsEvidenced efficiencies from avoided admissions ££303,518303,518 HFNLS activity resulting in CHP cost avoidanceHFNLS activity resulting in CHP cost avoidance ££151,410151,410 SubtotalSubtotal ££454,928454,928
Cost of HFNLSCost of HFNLS - - ££202,604202,604 SubtotalSubtotal ££252,324252,324
Average return on investment (ROI) per pt/per yearAverage return on investment (ROI) per pt/per year ££489489
If estimated £93,635 -148,933 added from improved If estimated £93,635 -148,933 added from improved referral and reduced rates of re-admission referral and reduced rates of re-admission £345,959- 401,257£345,959- 401,257
Potential ROI range per pt/per yrPotential ROI range per pt/per yr £671 - £779 £671 - £779
restricted externalrestricted external
Further patient related valueFurther patient related value
The New York Heart Association (NYHA) classification tool is The New York Heart Association (NYHA) classification tool is internationally recognised for the purpose of clinical assessmentinternationally recognised for the purpose of clinical assessment
Total 515 patients in service 2011/12. To gauge trend, two Total 515 patients in service 2011/12. To gauge trend, two recordings of NYHA Class required for each patient resulting in 430 recordings of NYHA Class required for each patient resulting in 430 records providing data illustrating the patient journey within the records providing data illustrating the patient journey within the HFNLS model of careHFNLS model of care
Outcomes:-Outcomes:- 56% report stable symptom control56% report stable symptom control 30% report improved symptom control 30% report improved symptom control 14% report decline in symptom control, of those 8% were end of 14% report decline in symptom control, of those 8% were end of
lifelife
Given low percentage of decline control, this supports data Given low percentage of decline control, this supports data regarding reduced admit rates from HFNLSregarding reduced admit rates from HFNLS
restricted externalrestricted external
Assessment of patient symptom Assessment of patient symptom burdenburden
Improve13130%
Decline - End of life
338%
Stable 24156%
Decline - Non-end of life
256%
Decline58
14%
Total:n430
restricted externalrestricted external
Patient Feedback MeasurePatient Feedback Measure
This year NHS TaysideThis year NHS Tayside’’s Specialist Nurses commissioned patients Specialist Nurses commissioned patient
feedback project regarding service value to patient experience usingfeedback project regarding service value to patient experience using
validated CARE measure tool (University of Glasgow) validated CARE measure tool (University of Glasgow)
50 questionnaires per service50 questionnaires per service
45 replies to date – 90% response rate 45 replies to date – 90% response rate
100% of patients reporting very good or excellent satisfaction in 100% of patients reporting very good or excellent satisfaction in areas such as listening, understanding concerns, positivity, care areas such as listening, understanding concerns, positivity, care and compassion, helping patients to take control and encouraging and compassion, helping patients to take control and encouraging partnership working.partnership working.
restricted externalrestricted external
Scottish Heart Failure Nurse Forum (SHFNF)
Established 7 years ago
Over 50 members representing all health boards in Scotland
Bi annual educational meetings
Support network, communicate good practice, representative of HF members
restricted externalrestricted external
Scottish Heart Failure Nurse Posts
restricted externalrestricted external
National caseload levels
restricted externalrestricted external
Key messagesKey messages
Heart Failure services appear to contribute in the avoidance Heart Failure services appear to contribute in the avoidance of admissions by improving management and by provision of admissions by improving management and by provision of rapid response facilityof rapid response facility
There are clear financial efficiencies for NHS Tayside There are clear financial efficiencies for NHS Tayside attached to this improvement from reduced re-admission attached to this improvement from reduced re-admission rates and LOSrates and LOS
Further benefits can be achieved from improving referral Further benefits can be achieved from improving referral strategiesstrategies
Community Health Partnerships benefit from avoided costs Community Health Partnerships benefit from avoided costs as evidenced in this work as evidenced in this work
restricted externalrestricted external
many thanksmany thanks